These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 11037882

  • 1. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A, Korn JH.
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 3. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y, Smith EA, LeRoy EC, Trojanowska M.
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [Abstract] [Full Text] [Related]

  • 4. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
    Santiago B, Galindo M, Rivero M, Pablos JL.
    Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
    [Abstract] [Full Text] [Related]

  • 5. Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic Fas-pathway.
    Chabaud S, Corriveau MP, Grodzicky T, Senécal JL, Chartier S, Raymond Y, Moulin VJ.
    J Cell Physiol; 2011 Jul; 226(7):1907-14. PubMed ID: 21506121
    [Abstract] [Full Text] [Related]

  • 6. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
    Liu T, Hu XD.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
    [Abstract] [Full Text] [Related]

  • 7. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M.
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [Abstract] [Full Text] [Related]

  • 8. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K.
    Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
    [Abstract] [Full Text] [Related]

  • 9. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H, Yamane K, Kubo M, Tamaki K.
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [Abstract] [Full Text] [Related]

  • 10. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T, Nishioka K.
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C, Rezzonico R, Ribbens C, Burger D, Wollheim FA, Dayer JM.
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [Abstract] [Full Text] [Related]

  • 12. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
    Kojc N, Zidar N, Vodopivec B, Gale N.
    Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
    [Abstract] [Full Text] [Related]

  • 13. Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts.
    McWhirter A, Colosetti P, Rubin K, Miyazono K, Black C.
    Lab Invest; 1994 Dec; 71(6):885-94. PubMed ID: 7807970
    [Abstract] [Full Text] [Related]

  • 14. Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation.
    Gu L, Zhu YJ, Guo ZJ, Xu XX, Xu WB.
    Acta Pharmacol Sin; 2004 Nov; 25(11):1479-88. PubMed ID: 15525471
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 16. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 18. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM.
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O.
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.